125 related articles for article (PubMed ID: 15960956)
1. [Prescription of cyclooxygenase-2 inhibitors: an intervention strategy in primary care].
Rosich I; Soler M; Tomás R; Crusat D
Gac Sanit; 2005; 19(3):229-34. PubMed ID: 15960956
[TBL] [Abstract][Full Text] [Related]
2. The outpatient utilization of non-steroidal anti-inflammatory drugs in South Bačka District, Serbia.
Calasan J; Mijatović V; Horvat O; Varga J; Sabo A; Stilinović N
Int J Clin Pharm; 2011 Apr; 33(2):246-51. PubMed ID: 21744192
[TBL] [Abstract][Full Text] [Related]
3. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors.
Fischer MA; Schneeweiss S; Avorn J; Solomon DH
N Engl J Med; 2004 Nov; 351(21):2187-94. PubMed ID: 15548779
[TBL] [Abstract][Full Text] [Related]
4. Evidence based educational outreach visits: effects on prescriptions of non-steroidal anti-inflammatory drugs.
Bernal-Delgado E; Galeote-Mayor M; Pradas-Arnal F; Peiró-Moreno S
J Epidemiol Community Health; 2002 Sep; 56(9):653-8. PubMed ID: 12177080
[TBL] [Abstract][Full Text] [Related]
5. Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors: analysis of prescriptions.
Pasina L; Nobili A; Tettamanti M; Riva E; Lucca U; Piccinelli R; Defendi L; Perego L; Lucifora S; Bulla C
Int J Clin Pharmacol Ther; 2010 Nov; 48(11):735-43. PubMed ID: 20979932
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of an academic detailing intervention in primary care on the prescribing of non-steroidal anti-inflammatory drugs.
Langaas HC; Hurley E; Dyrkorn R; Spigset O
Eur J Clin Pharmacol; 2019 Apr; 75(4):577-586. PubMed ID: 30596208
[TBL] [Abstract][Full Text] [Related]
7. Perception of the risk of gastrointestinal adverse drug reactions with non-steroidal anti-inflammatory drugs (including coxibs): differences among general practitioners, gastroenterologists and rheumatologists.
Montastuc JL; Bongard V; Lapeyre-Mestre M
Eur J Clin Pharmacol; 2003 Nov; 59(8-9):685-8. PubMed ID: 14556042
[TBL] [Abstract][Full Text] [Related]
8. Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
Teeling M; Bennett K; Feely J
Br J Clin Pharmacol; 2004 Mar; 57(3):337-43. PubMed ID: 14998430
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoepidemiological patterns of antidepressant prescribing in primary care in rural Spain (1995-1999).
Ruiz-Doblado S; Caraballo-Camacho Mde L
Int J Soc Psychiatry; 2002 Mar; 48(1):71-7. PubMed ID: 12008910
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of an educational feedback intervention on drug prescribing in dental practice.
Rauniar GP; Das BP; Manandhar TR; Bhattacharya SK
Kathmandu Univ Med J (KUMJ); 2012; 10(40):30-5. PubMed ID: 23575049
[TBL] [Abstract][Full Text] [Related]
11. [Trends of non-steroidal anti-inflammatory drugs use in Spain, 1990 through 2003].
de Abajo FJ; del Pozo JG; del Pino A
Aten Primaria; 2005 Nov; 36(8):424-33. PubMed ID: 16287555
[TBL] [Abstract][Full Text] [Related]
12. Performance associated effect variations of public reporting in promoting antibiotic prescribing practice: a cluster randomized-controlled trial in primary healthcare settings.
Tang Y; Liu C; Zhang X
Prim Health Care Res Dev; 2017 Sep; 18(5):482-491. PubMed ID: 28606190
[TBL] [Abstract][Full Text] [Related]
13. Examining product risk in context. Market withdrawal of zomepirac as a case study.
Ross-Degnan D; Soumerai SB; Fortess EE; Gurwitz JH
JAMA; 1993 Oct; 270(16):1937-42. PubMed ID: 8411550
[TBL] [Abstract][Full Text] [Related]
14. One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial.
Figueiras A; Sastre I; Tato F; Rodríguez C; Lado E; Caamaño F; Gestal-Otero JJ
Med Care; 2001 Feb; 39(2):158-67. PubMed ID: 11176553
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of proton pump inhibitors anti-ulcer drugs use in the Araba district primary care area].
Martínez Gorostiaga J; Echevarría Orella E; Calvo Hernáez B
Rev Esp Salud Publica; 2018 Aug; 92():. PubMed ID: 30100604
[TBL] [Abstract][Full Text] [Related]
16. Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors use in Australia and Nova Scotia (Canada).
Barozzi N; Sketris I; Cooke C; Tett S
Br J Clin Pharmacol; 2009 Jul; 68(1):106-15. PubMed ID: 19660008
[TBL] [Abstract][Full Text] [Related]
17. Assessment of nonsteroidal anti-inflammatory drug use pattern using World Health Organization indicators: A cross-sectional study in a tertiary care teaching hospital of Chhattisgarh.
R Vaishnavi PR; Gaikwad N; Dhaneria SP
Indian J Pharmacol; 2017; 49(6):445-450. PubMed ID: 29674799
[TBL] [Abstract][Full Text] [Related]
18. Adoption of new drugs by physicians: a survival analysis.
Garjón FJ; Azparren A; Vergara I; Azaola B; Loayssa JR
BMC Health Serv Res; 2012 Mar; 12():56. PubMed ID: 22401169
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of educational outreach visits compared with usual guideline dissemination to improve family physician prescribing-an 18-month open cluster-randomized trial.
Pinto D; Heleno B; Rodrigues DS; Papoila AL; Santos I; Caetano PA
Implement Sci; 2018 Sep; 13(1):120. PubMed ID: 30185197
[TBL] [Abstract][Full Text] [Related]
20. [The office visit and drug prescription in primary care].
Gómez-Calcerrada D; Pérez Flores D; Marset P
Gac Sanit; 1997; 11(2):105-7. PubMed ID: 9378571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
